Author Archives:

The Most Beautiful Place (And You’re Invited)

“The purpose of a [clinician] or any human in general should not be to simply delay the death of a patient, but to increase the person’s quality of life.” – Patch Adams, MD If you distilled the sweetest goodness of medicine, you’d get the Bay Area Cancer Connections. Twenty-five years ago, a patient and a

Read More

Partial Breast Radiation

The standard of care after lumpectomy for early-stage breast cancer typically includes whole breast radiation (WBI) to reduce the risk of local recurrence. WBI is usually delivered daily for 3–6 weeks. Several recent studies have investigated the effectiveness of accelerated partial breast irradiation (APBI), which restricts the radiation to the area of the original tumor.

Read More

Delaying Chemotherapy for Triple-Negative Breast Cancer Impacts Outcome

Triple-negative breast cancer is characterized by the lack of the estrogen receptor, progesterone receptor, and HER2 receptor. Chemotherapy is the mainstay of systemic treatment for this type of cancer. A study led by researchers in Peru found that the time to initiation of chemotherapy is important for women diagnosed with stage II-III triple-negative breast cancer.

Read More

The Benefits of Cannabis for Symptom Management

A 2017 Gallup poll indicated that 64% of Americans now support cannabis legalization, as many are turning to cannabis to safely and effectively treat symptoms related to neurological disorders, cancer, psychological disorders, gastrointestinal disease, infectious disease, and inflammatory disease. How can one plant help with so many conditions and have so few side effects? To

Read More

Bay Area Cancer Connections Announces Three New Board Members

Bay Area Cancer Connections (BACC), the largest nonprofit educator and free support network serving anyone affected by breast and ovarian cancer in the Bay Area, has appointed three new members to its board with extensive experience in finance, health care and medical marketing.   Press Release

Extended Endocrine Therapy with Aromatase Inhibitors

Five years of endocrine therapy with an aromatase inhibitor (AI) is highly effective in reducing the risk of recurrence of hormone-receptor-positive breast cancer; however, the risk continues beyond the five years of treatment. Researchers analyzed the combined results of 12 clinical trials involving 24,912 postmenopausal women with estrogen-receptor-positive disease to determine if there is a

Read More

Why Answering “How Are You” Is Difficult As a Cancer Patient

Many people are unaware of how difficult it is to answer social greetings when one is in crisis. They ask “how are you” mechanically, without thinking. I’ve done that in the past. Before my experience of cancer painfully opened my eyes to the stress of social greetings. I suddenly became one of many struggling everyday

Read More

Low-Dose Tamoxifen for ADH, LCIS, and DCIS

Tamoxifen is often used to prevent recurrence of hormonally driven breast cancer after surgery; however, it can cause significant side effects that adversely affect the quality of life of patients. It has previously been thought that a lower dose of tamoxifen (5 mg) might be as effective as the standard dose (20 mg), but with

Read More

Should Everyone Receive Genetic Testing Following a Breast Cancer Diagnosis?

Approximately 10% of breast cancers are due to an inherited genetic mutation. Not all women are referred for genetic testing following a breast cancer diagnosis. This is because many doctors follow the National Comprehensive Cancer Network (NCCN) guidelines, which recommend testing only those individuals who meet specific high-risk criteria. However, a new study suggests that current

Read More